Abstract
Cost-effectiveness analysis of a treatment is typically based on specific functions of the expectation of the effectiveness and cost of the treatment, and treatment comparisons are made in the same vein. The mathematical expectation has been the cornerstone for defining the incremental cost-effectiveness ratio and the incremental net benefit, the most popular tools for cost-effectiveness analysis for pairwise treatment comparisons. In this paper we propose a framework for cost-effectiveness analysis based on the whole posterior distribution of effectiveness and cost. We adopt a Bayesian perspective and use the predictive posterior distribution of the net benefit. The analysis based on the whole posterior distribution captures the uncertainty about the value of effectiveness and cost of the treatment and overcomes some limitations presented by the mean, as a summary measure, when skewed data are considered. Furthermore, it allows us to compare more than two treatments. An illustration with real data is provided.
Similar content being viewed by others
References
Al, M.J., van Hout, B.A.: A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty. Health Econ. 9, 599–609 (2000)
Ashby, D., Smith, A.F.M.: Evidence-based medicine as Bayesian decision-making. Stat. Med. 19, 3291–3202 (2000)
Bala, M.V., Zarkin, G.A., Mauskopf, J.: Presenting results of probabilistic sensitivity analysis: the incremental benefit curve. Health Econ. 17, 435–440 (2008)
Berger, J.: The case for objective Bayesian analysis. Bayesian Anal 1, 385–402 (2006)
Berger, J., Bernardo, J.M.: On the development of reference priors. In: Bernardo, J.M., Berger, J.O., Dawid, A.P., Smith, A.F.M. (eds.) Bayesian Statistics 4, pp. 35–60. Oxford University Press, Oxford (1992)
Berger, J., Bernardo, J.M., Sun, D.: Objective Bayesian inference. Technical Report (2006)
Briggs, A.H.: Handling uncertainty in economic evaluation. BMJ 319, 120–120 (1999a)
Briggs, A.H.: A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ. 8, 257–261 (1999b)
Briggs, A.H.: A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in Type 2 Diabetes. Int. J. Tech. Ass. Health Care 17, 69–82 (2001)
Fenwick, E., Claxton, K., Sculpher, M.: Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 10, 779–787 (2001)
Fryback, D.G., Chinnis, J.O., Ulvila, J.W.: Bayesian cost-effectiveness analysis. Int. J. Tech. Ass. Health Care 17, 83–97 (2001)
Gelman, A., Carlin, J.B., Stern, H.S., Rubin, D.B.: Bayesian Data Analysis (2nd ed.) Chapman & Hall/CRC, Boca Raton (2004)
Heitjan, D.F., Li, H.: Bayesian estimation of cost-effectiveness: an importance-sampling approach. Health Econ. 13, 191–198 (2004)
Heitjan, D.F., Moskowitz, A.J., Whang, W.: Bayesian estimation of cost-effectiveness ratios from clinical trials. Health Econ. 8, 191–201 (1999)
Hoch, J.S., Rockx, M.A., Krahn, A.: Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of “community acquired” syncope. BMC Health Services Res 6, 68 (2006)
Jakubczyk M., Kaminski B.: Cost-effectiveness acceptability curves—caveats quantified. Health Econ. (2009) doi:10.1002/hec.1534
Jeffreys, H.: Theory of Probability (3rd. ed.). Oxford University Press, New York (1961)
Jones, D.A.: Bayesian approach to the economic evaluation of health care technologies. In: Spicker (ed.) Quality of Life and Phamaeconomics in Clinical Trials, pp. 1189–1196. Lippincott-Raven, Philadelphia (1996)
Koerkamp, B.G., Hunink, M.G.M., Stijnen, T., Hammitt, J.K., Kuntz, K.M., Winstein, M.C.: Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis. Med. Decis. Making 27, 101–111 (2007)
Löthgren, M., Zethraeus, N.: Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ. 9, 623–630 (2000)
Mishan, E.J.: Evaluation of life and limb: a theoretical approach. J. Pol. Econ. 79, 687–705 (1971)
O’Hagan, A., Stevens, J.W.: A framework for cost-effectiveness analysis from clinical trial data. Health Econ. 10, 303–315 (2001)
O’Hagan, A., Stevens, J.W., Montmartin, J.: Bayesian cost-effectiveness analysis from clinical trial data. Stat. Med. 20, 733–753 (2001)
O’Hagan, A., Stevens, J.W.: Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Stat. Methods Med. Res. 1, 469–490 (2002)
Parmigiani, G.: Modelling in Medical Decision Making: A Bayesian Approach (Statistics in Practice). Wiley, Chichester (2002)
Pinto J.L., López C., Badía X., Coma A. et al.: Análisis coste-efectividad del tratamiento antirretroviral de gran actividad en pacientes infectados por el VIH asintomáticos. Medicina Clínica 114, 62–67 (2000)
Richardson G., Manca A.: Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 13, 1203–1210 (2004)
Spiegelhalter, D.J., Feedman, L.S., Parmar, M.K.B.: Bayesian approaches to randomized trials (with discussion). J. R. Stat. Soc. Ser. A 157, 357–456 (1994)
Stevens, J.W., O’Hagan, A., Miller, P.: Case study in the Bayesian analysis of a cost-effectiveness trial in the evaluation of health care technologies: depression. Pharm. Stat. 2, 51–68 (2003)
Stinnett, A.A., Mullahy, J.: Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med. Decis. Making 18, S68–S80 (1998)
Vanness, D.J., Mullahy, J.: Perspectives on mean-based evaluation of health care. In: Jones A.M. (ed.) Elgar Companion to Health Economics, pp. 526–536. Edward Elgar Publishing, Cheltenham (2006)
Acknowledgements
This research has been partially support by the grants SEJ-02814 (Junta de Andalucía), SEJ2007-65200, SEJ2006-12685 (Ministerio de Educación y Ciencia (MEC), Spain) and ECO2009-14152 (MICINN, Spain).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreno, E., Girón, F.J., Vázquez-Polo, F.J. et al. Complementing information from incremental net benefit: a Bayesian perspective. Health Serv Outcomes Res Method 10, 86–99 (2010). https://doi.org/10.1007/s10742-010-0059-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10742-010-0059-x